Thompson Davis & Co’s Repligen RGEN Stock Holding History

Thompson Davis & Co’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-800	Closed	-$212K	–	136
2021 Q4	$212K	Buy	+800	New	+$216K	0.18%	99
2018 Q3	$8K	Buy	150 +100	+200%	+$5.15K	0.02%	497
2018 Q2	$2K	Buy	+50	New	+$2.06K	﹤0.01%	620
2014 Q4	–	Sell	-1,750	Closed	-$35K	–	1244
2014 Q3	$35K	Hold	1,750	–	–	0.05%	343
2014 Q2	$40K	Hold	1,750	–	–	0.06%	289
2014 Q1	$23K	Sell	1,750 -16,000	-90%	-$229K	0.04%	363
2013 Q4	$242K	Buy	+17,750	New	+$212K	0.37%	71

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Thompson Davis & Co's RGEN Position: Q1 2022 in Review

Thompson Davis & Co sold out of Repligen (RGEN) in Q1 2022, closing a stake of 800 shares — an estimated $212K sold.

Thompson Davis & Co first reported a position in RGEN in Q4 2013 and held it in 7 quarters. The position peaked at $242K in Q4 2013. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

Thompson Davis & Co reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
Thompson Davis & Co sold 800 Repligen shares in Q1 2022, an estimated $212K.
Thompson Davis & Co first reported a position in Repligen in Q4 2013 and held it in 7 quarters.
Thompson Davis & Co's Repligen position peaked at $242K in Q4 2013.
450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Thompson Davis & Co's 13F filing for Q1 2022, filed 13 May 2022.